Mark E. Cooper

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen et al. · New England Journal of Medicine · 2009 · 2.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

Assam El‐Osta, Daniella Brasacchio, Dachun Yao et al. · The Journal of Experimental Medicine · 2008 · 1.1K citations · Full text

Medicine, Genetics, Molecular Biology +14

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen et al. · JAMA · 2018 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E. de Galan et al. · Journal of the American Society of Nephrology · 2009 · 973 citations · Full text

Medicine, Endocrinology, Nephrology +17